PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.\', \'UQ Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, Queensland, Australia. Electronic address: a.shafiee@uq.edu.au.\', \'Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: smmhashemi@sbmu.ac.ir.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0024-3205(20)31246-710.1016/j.lfs.2020.118493
?:doi
?:hasPublicationType
?:journal
  • Life sciences
is ?:pmid of
?:pmid
?:pmid
  • 32979360
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.071
?:rankingScore_hIndex
  • 145
?:title
  • Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all